CoChat
Sign Up
Cited by 326Bone health and osteoporosis researchTreatment of Major DepressionBone Metabolism and Diseases

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

Use of Antidepressants and Rates of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures

Diem, Susan J.·2007·Archives of Internal Medicine
DOI 10.1001/archinte.167.12.1240
Open this paper in CoChat — free account

Abstract

BACKGROUND: Serotonin transporters have recently been described in bone, raising the possibility that medications that block serotonin reuptake could affect bone metabolism. METHODS: We assessed current use of selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) and obtained serial bone mineral density (BMD) measurements in a cohort of 2722 older women (mean age, 78.5 years) participating in the Study of Osteoporotic Fractures, a prospective cohort study of community-dwelling women. Hip BMD was measured at the sixth examination and an average of 4.9 years later at the eighth examination. We categorized women as nonusers (used no SSRIs or TCAs at either examination; n=2406), SSRI users (used SSRIs but no TCAs at either examination; n=198), or TCA users (used TCAs but no SSRIs at either examination; n=118). Depressive symptoms were identified using a cutoff score of at least 6 on the Geriatric Depression Scale. RESULTS: After adjustment for potential confounders, including the Geriatric Depression Scale score, mean total hip BMD decreased 0.47% per year in nonusers compared with 0.82% in SSRI users (P<.001) and 0.47% in TCA users (P=.99). Higher rates of bone loss were also observed at the 2 hip subregions for SSRI users. Results were not substantially altered when women who scored at least 6 on the Geriatric Depression Scale were excluded from the analysis. CONCLUSION: Use of SSRIs but not TCAs is associated with an increased rate of bone loss at the hip in this cohort of older women.

Overview

Integrity signals

Registry

Crossref · 10.1001/archinte.167.12.1240

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Diem, S. J.
Affiliations
University of Minnesota (US)
Corresponding author
Diem, Susan J.
ORCID
Diem, Susan J.
Venue
Archives of Internal Medicine
Publisher
American Medical Association (AMA)
Published
2007-06-25
Volume
167
Issue
12
Pages
1240
ISSN
0003-9926 (ISSN-L)
DOI
10.1001/archinte.167.12.1240
OpenAlex
W2090973045
Cited by
326
References
32
Citations by year
2026: 4 · 2025: 2 · 2024: 7 · 2023: 10 · 2022: 11 · 2021: 8 · 2020: 12 · 2019: 6 · 2018: 19 · 2017: 15 · 2016: 19 · 2015: 18 · 2014: 22 · 2013: 22 · 2012: 25
FWCI
33.22
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (R01AG008415, AG05394, AG 08415, AG-05407)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR035584, K23AR051926, AR35583, AR-35584, AR 35582, R01AR035582, R01AR035583)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
antidepressants, selective serotonin reuptake inhibitors, tricyclic antidepressants, bone loss, hip bone density, osteoporosis, older women, serotonin transporter, bone metabolism, depressive symptoms, Study of Osteoporotic Fractures
MeSH terms
Aged, Antidepressive Agents, Tricyclic, Bone Resorption, Depression, Female, Follow-Up Studies, Hip Fractures, Humans, Osteoporosis, Prognosis, Prospective Studies, Surveys and Questionnaires, Risk Factors, Time Factors, United States, Absorptiometry, Photon, Bone Density, Incidence, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review